x
Filter:
Filters applied
- Coronavirus (COVID-19) CollectionRemove Coronavirus (COVID-19) Collection filter
- Rapid CommunicationRemove Rapid Communication filter
- SeroprevalenceRemove Seroprevalence filter
- 2020 - 2022Remove 2020 - 2022 filter
Coronavirus (COVID-19) Collection
1 Results
- Short CommunicationOpen Access
High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
International Journal of Infectious DiseasesVol. 109p244–246Published online: July 11, 2021- Susy Fanny Núñez-Zapata
- Bruno Benites-Peralta
- Percy Mayta-Tristan
- Alfonso J. Rodríguez-Morales
Cited in Scopus: 10There has been intense discussion about the importance of reaching herd immunity to achieve global population protection status against SARS-CoV-2/COVID-19. For that reason, vaccination coverage and seroprevalence studies are increasing around the world; some of them have shown an increase in the seroprevalence of different populations. For example, a recent study in Jordan (Sughayer et al., 2021) stated the importance of seroprevalence studies for SARS-CoV-2 infection among healthy blood donors.
